Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

ASTRAZENECA PLC (AZN) Form 6-K — Sep 1, 2026

$AZNForm 6-KFiled Sep 1, 2026, 12:20 PM ET0001654954-26-008042Original filing

AstraZeneca PLC filed a Form 6-K furnishing a UK notification (POATRs PRM 1.6.4R) that 10,072 new ordinary shares of $0.25 each were admitted to trading on the Main Market of the London Stock Exchange. The shares were issued under the company's employee share schemes between 1 August 2026 and 31 August 2026, admitted under the existing block admission dated 29 January 2021, and are fully fungible with existing ordinary shares. Following the admission, total ordinary shares in issue stand at 1,551,043,461.

Key figures

Shares Offered
10072
Shares Outstanding
1551043461
Isin
GB0009895292
Scheme Type
employee share schemes
Share Class
Ordinary Shares of $0.25 each
Fungibility
Fully fungible with existing Ordinary Shares
Issuance Window
1 August 2026 to 31 August 2026
Regulated Market
London Stock Exchange - Main Market
Block Admission Date
29 January 2021

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    ASTRAZENECA PLC (AZN) Form 6-K — Sep 1, 2026: AI Analysis | Signal8